Phase II trial of pyrazoloacridine in advanced non-small cell carcinoma of the lung--a Kansas Cancer Institute and Thompson Cancer Survival Center Study. [electronic resource]
Producer: 20030404Description: 339-42 p. digitalISSN:- 0167-6997
- Acridines -- administration & dosage
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- administration & dosage
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Dose-Response Relationship, Drug
- Female
- Humans
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Pyrazoles -- administration & dosage
- Survival Analysis
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.